
Enzyme
Enzyme is a YC Summer 2017 (S17) company. Based in San Francisco, CA, USA; Remote. Team of 32.
About Enzyme
Summary
Enzyme builds cloud-based quality management system software for medical device, digital health, and biopharma companies navigating FDA approval and ongoing regulatory compliance. The platform covers document control, change control, risk management, CAPA, audits, and the full premarket-to-postmarket lifecycle, replacing the manual processes and disconnected tools that life science teams typically cobble together. Enzyme also provides QA and RA consulting to support companies through the regulatory process directly.
Business model
Subscription-based SaaS with optional QA/RA consulting services.
Go-to-market
Life science companies, from early-stage startups to IPO-stage firms, adopt the platform via a sales-led motion with demo-request entry points on the website.
From the Y Combinator listing
Automating regulatory approval & compliance for life science companies
Enzyme provides online quality management system software and supportive QA/RA consulting, helping life science companies with FDA approval and ongoing compliance. Enzyme staff has over 50 years of medical device industry experience, across several Fortune 500 companies and startups.
Facts
- Healthcare / Healthcare -> Healthcare IT
- San Francisco, CA, USA; Remote
- 32
- Acquired
- Early
Founders (2)
- Jacob Graham
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works